Safety and Immunogenicity of an HIV Adenoviral Vector Boost after DNA Plasmid Vaccine Prime by Route of Administration: A Randomized Clinical Trial.

Publication Type:

Journal Article


PloS one, Volume 6, Issue 9, p.e24517 (2011)


2011, Center-Authored Paper, Clinical Research Division, Vaccine and Infectious Disease Division


In the development of HIV vaccines, improving immunogenicity while maintaining safety is critical. Route of administration can be an important factor.